Fasting Versus Non-fasting on Outcomes and Satisfaction Prior to Cardiac Catheterization

NCT ID: NCT05851872

Last Updated: 2024-05-16

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

169 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-03-01

Study Completion Date

2023-12-05

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Moderate sedation is used in the catheterization laboratory relieve the anxiety and discomfort associated with access and other aspects of the procedure. Whether being in a fasting state (nothing per os, NPO) at the time of the procedure is beneficial or harmful is not well known, but patients are typically required to be fasting at the time of elective procedures, guidance derived from procedures that require general anesthesia. Whereas the typical thinking was that fasting prior to procedures would minimize the risk of aspiration in the event of intubation, or nausea and other symptoms generally, several studies have shown that prolonged fasting prior to procedures is associated with increased nausea, vomiting, aspiration and procedure recovery time.

We aim to evaluate patient satisfaction, nausea and immediate outcomes of patients who are not kept NPO prior to cardiac catheterization.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Heart Diseases

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Fasting group

Participant will be asked to fast at least 6 hours prior to the procedure

Group Type ACTIVE_COMPARATOR

Coronary angiogram

Intervention Type PROCEDURE

Being done per standard of care

Right heart catheterization

Intervention Type PROCEDURE

Being done per standard of care

Non-Fasting group

Participants will be allowed to eat and drink up to 1 hour prior to the procedure.

Group Type EXPERIMENTAL

Coronary angiogram

Intervention Type PROCEDURE

Being done per standard of care

Right heart catheterization

Intervention Type PROCEDURE

Being done per standard of care

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Coronary angiogram

Being done per standard of care

Intervention Type PROCEDURE

Right heart catheterization

Being done per standard of care

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* \>18 years of age
* Requiring a cardiac catheterization as per standard of care
* Elective procedure with planned moderate sedation

Exclusion Criteria

* BMI \>45
* All emergent procedures
* All mechanical circulatory support-assisted procedures
* Other high risk procedures (as identified by the operator)
* Pregnant women
* Hemodynamically unstable patients
* Active GI illness, including nausea at the time of screening
* Taking chronic pain medications at home or on current brief course of narcotics
* Dementia
* Encephalopathy
* Patients scheduled for deep sedation
* Severe GERD (if the patient requires more than one medication for adequate control of GERD symptoms or has required medical intervention within the past year)
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Virginia Commonwealth University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Zachary Gertz, MD

Role: PRINCIPAL_INVESTIGATOR

Virginia Commonwealth University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Virginia Commonwealth University

Richmond, Virginia, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

HM20025962

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Memory & Conditioning Under Anesthesia
NCT04062123 COMPLETED PHASE1
Sedation and Memory Consolidation
NCT05045170 COMPLETED NA
Recovery From General Anesthesia
NCT00165971 COMPLETED NA